Isolation and Characterization of the Fungal Metabolite 3-O-Methylviridicatin as an Inhibitor of Tumour Necrosis Factor -Induced Human Immunodeficiency Virus Replication

Antiviral Chemistry and Chemotherapy - United Kingdom
doi 10.1177/095632029800900206
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Isolation and Characterization of Novel Human Immunodeficiency Virus Integrase Inhibitors From Fungal Metabolites

Antiviral Chemistry and Chemotherapy
MedicineVirologyDrug DiscoveryPharmacology
1999English

Isolation and Characterization of Human Immunodeficiency Virus Type-1 Mutants Resistant to the Non-Nucleotide Reverse Transcriptase Inhibitor MKC-442

Antiviral Chemistry and Chemotherapy
MedicineVirologyDrug DiscoveryPharmacology
1995English

Tumor Necrosis Factor Alpha Functions in an Autocrine Manner in the Induction of Human Immunodeficiency Virus Expression.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1990English

Requinomycin, an Inhibitor of R-Factor Transfer: Isolation, Characterization and Properties

Journal of Antibiotics
Drug DiscoveryPharmacology
1972English

Pentoxifylline and Tumour Necrosis Factor-Induced Lung Injury

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1994English

Isolation and Preliminary Characterization of a Recombinant TAT Protein From Human Immunodeficiency Virus.

1995English

Carnitine and Congeners as Regulators of Tumour Necrosis Factor

Mediators of Inflammation
ImmunologyCell Biology
1993English

The Relationship Between Tumor Necrosis Factor and Human Immunodeficiency Virus Gene Expression in Lymphoid Tissue.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1997English

Isolation and Study of an Acquired Inhibitor of Human Coagulation Factor V.

Journal of Clinical Investigation
Medicine
1986English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy